InMode Ltd. (INMD) News
Filter INMD News Items
INMD News Results
|Loading, please wait...|
INMD News Highlights
- INMD's 30 day story count now stands at 9.
- Over the past 29 days, INMD's stories per day has been in a clear downtrend, falling by about 0.18 per 6 days.
- The most mentioned tickers in articles about INMD are NOTE, AMZN and MD.
Latest INMD News From Around the Web
Below are the latest news stories about INMODE LTD that investors may wish to consider to help them evaluate INMD as an investment opportunity.
Could These 2 Growth Stocks Outperform Amazon in 2023?
Despite being one of the world's largest, most steadily growing businesses, Amazon's (NASDAQ: AMZN) stock fell by around 40% in the last 12 months, leaving investors looking for alternatives to buy for growth. At the same time, analysts anticipate that lesser-known growth stocks like InMode (NASDAQ: INMD) and Green Thumb Industries (OTC: GTBIF) will see their shares climb by 63% and 152%, respectively, which would mean they'd blow Amazon out of the water.
Got $100? These 2 Stocks Could Be Bargain Buys for 2023 and Beyond
Teladoc specializes in virtual medical visits and sells its plans to companies and organizations. Teladoc also sells its BetterHelp mental health online consultations directly to consumers. What's weighed on the stock is the fact that Teladoc hasn't yet turned that revenue into profit.
InMode's (NASDAQ:INMD) three-year total shareholder returns outpace the underlying earnings growth
InMode Ltd. ( NASDAQ:INMD ) shareholders have seen the share price descend 19% over the month. In contrast, the return...
InMode Updates It Does Not Hold Cash Deposits at SVB
InMode Ltd. (NASDAQ: INMD), a leading global provider of innovative medical technologies, announced today that that it does not hold cash deposits or securities at Silicon Valley Bank. The company maintains its cash and non-insured deposits at U.S. money center banks and large Israeli financial institutions. As a result, the company does not expect the closure of Silicon Valley Bank to have an impact on its operations. The company will monitor for any effect on its suppliers, vendors and other s
2 Exceptional Growth Stocks That Could Jump 37.6% to 40.2% Higher, According to Wall Street
These businesses are at the top of their respective industries, but you wouldn't know it by looking at their stock prices.
Don't Miss Out on These 2 Undervalued Stocks With Huge Growth Potential
The market doesn't always get a growth stock's valuation right, and when it's wrong, there's often an opportunity to make a hearty dollop of dosh -- and it's always good to feel as if you're a step ahead of the market. On that note, two growth stocks look favorably priced right now, and there's good reason to think they'll keep growing in the years ahead. Israeli medical aesthetics company InMode (NASDAQ: INMD) is a stellar investment opportunity thanks to its slightly cheap shares and its finely tuned growth engine.
InMode to Present In-Person at the Barclays Global Health Conference
InMode Ltd. (Nasdaq: INMD), a leading global provider of innovative medical technologies, today announced that Yair Malca, Chief Financial Officer and Spero Theodorou MD, Chief Medical Officer, will present in-person at the Barclays Global Health Conference in Miami on March 15, 2023.
2 High-Growth Stocks That Could Double Your Money in 5 Years or Less
Wall Street analysts are expecting that 23andMe's (NASDAQ: ME) stock will hit around $5.69 within a year, which means they think it can grow to more than double its current price of $2.61. In 2019, it reported sales of $156.3 million, which means that its compound annual growth rate (CAGR) from 2019 through 2024 would be 31.3%.
Get Ready to Soar: 2 High-Octane Growth Stocks Wall Street Expects to Climb in 2023
Wall Street analysts aren't always right with their predictions about stocks, but they typically have a strong argument for why they think a given outcome is going to happen. On that note, let's evaluate a couple of growth stocks that Wall Street has high hopes for to see if they might be a good fit for your portfolio. When it comes to businesses making medical aesthetics treatments that are alternatives to plastic surgeries and face lifts, InMode (NASDAQ: INMD) is a leader.
3 Under-the-Radar Growth Stocks with Promising Fundamentals
Maximize your chances of success in the stock market by investing in these under-the-radar growth stocks that are trading at a discount.